Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • DYRK
    (7)
  • CDK
    (3)
  • Casein Kinase
    (3)
  • Apoptosis
    (1)
  • ERK
    (1)
  • GSK-3
    (1)
  • MDM-2/p53
    (1)
  • NF-κB
    (1)
  • Pim
    (1)
  • Others
    (4)
TargetMol | Tags By ResearchField
  • Cancer
    (9)
Filter
Search Result
Results for "

hipk2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    12
    TargetMol | All_Pathways
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Antibody Products
    2
    TargetMol | Antibody_Products
CK2/ERK8-IN-1
TMCB
T108271085822-09-8In house
CK2/ERK8-IN-1 (TMCB) is a dual inhibitor of casein kinase 2 (CK2) (Ki: 0.25 µM) and ERK8 (IC50s: 0.50 μM) with pro-apoptotic efficacy. CK2/ERK8-IN-1 also binds to PIM1, DYRK1A, and HIPK2 (Kis: 8.65 µM, 11.9 µM, and 15.25 µM).
  • $30
In Stock
Size
QTY
tBID
T130961639895-85-4
tBID is a selective homeodomain-interacting protein kinase 2 (HIPK2) inhibitor (IC50 of 0.33 µM)
  • $1,698
6-8 weeks
Size
QTY
Protein kinase inhibitors 1
T46361365986-44-2
Protein kinase inhibitors 1 is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM.
  • Inquiry Price
1-2 weeks
Size
QTY
Protein kinase inhibitors 1 hydrochlorid
Protein kinase inhibitors 1 hydrochlorid (1365986-44-2(free base))
T4692
Protein kinase inhibitors 1 hydrochlorid (Protein kinase inhibitors 1 hydrochlorid (1365986-44-2(free base))) is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM.
  • $37
In Stock
Size
QTY
BT173
T99532232180-74-2
BT173 is a novel inhibitor of homeodomain interacting protein kinase 2 (HIPK2 ), attenuating renal fibrosis through suppression of the TGF-ß1/Smad3 pathway.
  • $89
In Stock
Size
QTY
Abemaciclib
LY2835219, CDK4/6 dual inhibitor
T23811231929-97-7
Abemaciclib (LY2835219) is a dual inhibitor of CDK4/6 (IC50=2/10 nM) with selectivity and specificity. Abemaciclib has antitumor activity and is used to treat advanced or metastatic breast cancer.
  • $48
In Stock
Size
QTY
TargetMol | Citations Cited
Abemaciclib methanesulfonate
LY2835219 mesylate, LY2835219 (methanesulfonate), LY2835219, abemaciclib mesylate
T31111231930-82-7
Abemaciclib methanesulfonate (LY2835219) is a specific and effective inhibitor of CDK4(IC50=2 nM) and CDK6(IC50=10 nM).
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
XRF-1021
T2144892968523-32-0
XRF-1021 is an orally active HIPK2 inhibitor with an IC50 value of 0.18 μM. It reduces the expression of fibrosis markers such as fibronectin, type I collagen, and α-SMA in NRK-49F and HK-2 cells stimulated by TGF-β1. XRF-1021 blocks signaling pathways including TGF-β, NF-κB, p53, Wnt/β-catenin, and Notch. Additionally, it alleviates renal injury and fibrosis in vivo and can be utilized for research in chronic kidney disease.
  • Inquiry Price
10-14 weeks
Size
QTY
TBB
NSC 231634, Casein Kinase II Inhibitor I, 4,5,6,7-tetrabromobenzotriazole
T269517374-26-4
TBB (NSC-231634)(NSC-231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2).
  • $38
In Stock
Size
QTY
TargetMol | Citations Cited
Protein kinase inhibitors 1 hydrochloride
T398602321337-71-5
Protein Kinase Inhibitors 1 Hydrochloride effectively inhibits HIPK2, demonstrating high potency with IC50 values of 136 nM for HIPK1 and 74 nM for HIPK2, alongside a dissociation constant (Kd) of 9.5 nM for HIPK2.
  • $82
5 days
Size
QTY
DMAT
CK2 Inhibitor, Casein kinase II Inhibitor
T7390749234-11-5
DMAT (Casein kinase II Inhibitor) is a potent and specific inhibitor of CK2(IC50 value of 130 nM).
  • $56
In Stock
Size
QTY
MU1787
T2132642624098-97-9
MU1787 (Compound 22h) is an inhibitor of homotypic interaction domain protein kinases (HIPK), displaying IC50 values of 285 nM for HIPK1, 123 nM for HIPK2, and 283 nM for HIPK3. HIPKs have distinct or sometimes opposing roles in cell proliferation and tissue growth.
  • Inquiry Price
10-14 weeks
Size
QTY